Angio-oedèmes iatrogènes : particularités cliniques. La Revue de Médecine Interne, Juin, vol.27, issue.2, pp.73-75, 2006. ,
DOI : 10.1016/j.revmed.2006.03.011
Angioedema, Clinical Reviews in Allergy & Immunology, vol.23, issue.2, pp.217-232, 2002. ,
DOI : 10.1385/CRIAI:23:2:217
Les angioedèmes bradykiniques héréditaires ou acquis. La Revue de Médecine Interne, 2010. ,
DOI : 10.1016/j.revmed.2009.11.021
Nonallergic angioedema: role of bradykinin, Allergy, vol.77, issue.6, pp.842-856, 2007. ,
DOI : 10.1111/j.1398-9995.2006.01197.x
Acquired angioneurotic edema caused by acquired deficiency of C1 esterase inhibitor disclosing lymphoproliferative syndrome. Apropos of a case, review of the literature], Ann Dermatol Venereol, vol.109, issue.12, pp.1049-1056, 1982. ,
An IgG autoantibody which inactivates C1??-inhibitor, Nature, vol.84, issue.6090, pp.722-724, 1986. ,
DOI : 10.7326/0003-4819-84-5-580
Plasma bradykinin in angio-oedema. The Lancet, Juin, vol.6351, issue.9117, pp.1693-1697, 1998. ,
Functional C1-Inhibitor diagnostics in hereditary angioedema: Assay evaluation and recommendations, Journal of Immunological Methods, vol.338, issue.1-2, pp.14-20, 2008. ,
DOI : 10.1016/j.jim.2008.06.004
URL : https://hal.archives-ouvertes.fr/hal-00400706
Frequent de novo mutations and exon deletions in the C1inhibitor gene of patients with angioedema, Journal of Allergy and Clinical Immunology, vol.106, issue.6, pp.1147-1154, 2000. ,
DOI : 10.1067/mai.2000.110471
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond, Journal of Allergy and Clinical Immunology, vol.114, issue.3, pp.51-131, 2004. ,
DOI : 10.1016/j.jaci.2004.06.047
Les angioedèmes bradykiniques acquis. La Revue de Médecine Interne 31, pp.32-34, 2010. ,
DOI : 10.1016/j.revmed.2010.03.005
Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy, The American Journal of Medicine, vol.114, issue.4, pp.294-298, 2003. ,
DOI : 10.1016/S0002-9343(02)01526-7
T cell???mediated reactions to iodinated contrast media: Evaluation by skin and lymphocyte activation tests, Journal of Allergy and Clinical Immunology, vol.115, issue.1, pp.179-185, 2005. ,
DOI : 10.1016/j.jaci.2004.09.012
Angioedema due to angiotensin-converting enzyme inhibitors, Immunopharmacology, vol.44, issue.1-2, pp.21-25, 1999. ,
DOI : 10.1016/S0162-3109(99)00107-1
Widal triad (Asthma-Nasal polyposis-aspirin intolerance): an inflammatory metabolism abnormality], Rev Med Suisse, vol.1, issue.1, pp.15-23, 2005. ,
Complement-dependent histamine release from rat peritoneal mast cells, induced by lipopolysaccharides from Bacteroides oralis, Fusobacterium nucleatum and Veillonella parvula, Journal of Oral Pathology and Medicine, vol.2, issue.2, pp.87-94, 1981. ,
DOI : 10.1902/jop.1977.48.9.497
Superior Vena Cava Syndrome, Emergency Medicine Clinics of North America, vol.27, issue.2, pp.243-255, 2009. ,
DOI : 10.1016/j.emc.2009.01.003
Le syndrome de Gleich. Un cas et revue de la littérature. La Revue de Médecine Interne, Fév, vol.26, issue.2, pp.137-140, 2005. ,
MELKERSSON-ROSENTHAL SYNDROME AND OROFACIAL GRANULOMATOSIS, Dermatologic Clinics, vol.14, issue.2, pp.371-380, 1996. ,
DOI : 10.1016/S0733-8635(05)70363-6
Blepharochalasis: A Rare Condition Misdiagnosed as Recurrent Angioedema, Archives of Dermatology, vol.145, issue.4, pp.498-499, 2009. ,
DOI : 10.1001/archdermatol.2009.19
Angioedema and systemic lupus erythematosus--a complementary association? Ann Acad Med Singapore, Fév, vol.36, issue.2, pp.142-147, 2007. ,
Angioedema as a single manifestation of carcinoid syndrome in a bronchial carcinoid tumor, Allergologia et Immunopathologia, vol.32, issue.4, pp.235-237, 2004. ,
DOI : 10.1016/S0301-0546(04)79246-0
Cutaneous angiosarcoma presenting as recurrent angio-oedema of the face, British Journal of Dermatology, vol.16, issue.6, pp.1346-1348, 2000. ,
DOI : 10.1001/archderm.135.9.1035
Elephantiasis nostras of the lips, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.84, issue.3, pp.297-300, 1997. ,
DOI : 10.1016/S1079-2104(97)90347-4
Hypocomplementemia with cutaneous vasculitis and arthritis. Possible immune complex syndrome, Mayo Clin. Proc. Mai, vol.48, issue.5, pp.340-348, 1973. ,
Le systeme rénine-angiotensine : son rôle dans le controle de la pression et dans l'hypertension. Précis de physiologie médicale, deuxiéme édition, IVchapitre, vol.19, pp.221-228, 2000. ,
The ongoing telmisartan alone and in combination with ramipril global endpoint trial program. The American Journal of Cardiology, Mai, vol.2291, issue.10, pp.28-34, 2003. ,
Angiotensin Receptor Blockers versus Angiotensin-Converting Enzyme Inhibitors: Where Do We Stand Now? The American Journal of Cardiology, Aoû, vol.6100, issue.3, pp.38-44, 2007. ,
Pathophysiological regulation of the AT1-receptor and implications for vascular disease, Journal of Hypertension, vol.24, issue.Suppl 1, pp.15-21 ,
DOI : 10.1097/01.hjh.0000220402.53869.72
Angiotensinconverting enzyme inhibition improves cardiac function. Role of bradykinin, Hypertension, 1994. ,
DOI : 10.1161/01.hyp.23.4.411
URL : http://hyper.ahajournals.org/content/hypertensionaha/23/4/411.full.pdf
Seven decades of angiotensin Peptides, imshealth.com 2007 top therapeutic Classes by RX. Consulté le, pp.1945-1950, 1939. ,
Renal Function and Effectiveness of Angiotensin-Converting Enzyme Inhibitor Therapy in Patients With Chronic Stable Coronary Disease in the Prevention of Events with ACE inhibition (PEACE) Trial, Circulation, vol.114, issue.1, pp.26-31, 2006. ,
DOI : 10.1161/CIRCULATIONAHA.105.592733
Angiotensin-Converting Enzyme Inhibitors: A New Mechanism of Action, Circulation, vol.112, issue.16, pp.2436-2445, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.104.528695
Rationale for the Chemical Development of Angiotensin II Receptor Antagonists, American Journal of Hypertension, vol.5, issue.12_Pt_2, 1992. ,
DOI : 10.1093/ajh/5.12.209S
Telmisartan in High-Risk Cardiovascular Patients. The American Journal of Cardiology, Jan, vol.4105, issue.1, pp.36-43, 2010. ,
Losartan Chemistry and Its Effects via AT1 Mechanisms in the Kidney, Current Medicinal Chemistry, vol.16, issue.28, p.3701, 2009. ,
DOI : 10.2174/092986709789105000
Is there a future for direct renin inhibitors?, Expert Opinion on Investigational Drugs, vol.118, issue.1, pp.653-661 ,
DOI : 10.1185/03007990802336541
Direct Renin Inhibition-Commonly Asked Questions. The Journal of Clinical Hypertension, pp.871-875, 2008. ,
DOI : 10.1111/j.1751-7176.2008.00039.x
URL : http://onlinelibrary.wiley.com/doi/10.1111/j.1751-7176.2008.00039.x/pdf
Lessons learned from the ONTARGET and TRANSCEND trials, Current Atherosclerosis Reports, vol.372, issue.5, pp.371-376 ,
DOI : 10.7326/0003-4819-117-3-234
Pathways for bradykinin formation and inflammatory disease, Journal of Allergy and Clinical Immunology, vol.109, issue.2, pp.195-209, 2002. ,
DOI : 10.1067/mai.2002.121316
Hypertension and the bradykinin system, Current Hypertension Reports, vol.26, issue.3, pp.178-181 ,
DOI : 10.1007/s11906-009-0032-7
Angiotensin???converting enzyme (ACE) inhibitors and angio???oedema, British Journal of Dermatology, vol.119, issue.2, pp.153-158, 1997. ,
DOI : 10.1016/S0140-6736(94)91774-4
Bradykinin receptors and their antagonists, European Journal of Pharmacology, vol.348, issue.1, pp.1-10, 1998. ,
DOI : 10.1016/S0014-2999(98)00165-4
Bradykinin receptors General Pharmacology: The Vascular System, pp.1-6, 1997. ,
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) Regulatory Peptides, 1996. ,
The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K+ channels and activation of Ca2+-activated Cl??? channels, Journal of Clinical Investigation, vol.120, issue.4, pp.1240-1252 ,
DOI : 10.1172/JCI41084DS1
Stimulation of Bradykinin B1 Receptors Induces Vasodilation in Conductance and Resistance Coronary Vessels in Conscious Dogs : Comparison With B2 Receptor Stimulation, Circulation, vol.101, issue.15, pp.1848-1853, 2000. ,
DOI : 10.1161/01.CIR.101.15.1848
Role of the B1 Kinin Receptor in the Regulation of Cardiac Function and Remodeling After Myocardial Infarction, Hypertension, vol.45, issue.4, pp.747-753, 2005. ,
DOI : 10.1161/01.HYP.0000153322.04859.81
A Stable Metabolite, Arg-Pro-Pro-Gly-Phe, of Bradykinin in the Degradation Pathway in Human Plasma., The Japanese Journal of Pharmacology, vol.60, issue.2, pp.111-119, 1992. ,
DOI : 10.1254/jjp.60.111
Angiotensin-Converting Enzyme Inhibitor-Associated Angioedema Is Characterized by a Slower Degradation of des-Arginine9-Bradykinin, Journal of Pharmacology and Experimental Therapeutics, vol.303, issue.1, 2002. ,
DOI : 10.1124/jpet.102.038067
Inhibition of Aminopeptidase P Potentiates Wheal Response to Bradykinin in Angiotensin-Converting Enzyme Inhibitor-Treated Humans, Journal of Pharmacology and Experimental Therapeutics, vol.292, issue.1, pp.295-298, 2000. ,
Dipeptidyl Peptidase IV Activity in Patients With ACE-Inhibitor-Associated Angioedema. Hypertension, Fév, vol.139, issue.2, pp.460-464, 2002. ,
Effect of a new aminopeptidase P inhibitor, apstatin, on bradykinin degradation in the rat lung, J Pharmacol Exp Ther. Déc, vol.275, issue.3, pp.1136-1178, 1995. ,
Aminopeptidase P in individuals with a history of angio-oedema on ACE inhibitors. The Lancet, Juin, vol.15359, issue.9323, pp.2088-2089, 2002. ,
Angiotensin converting enzyme inhibitor induced angio-oedema: a review of the pathophysiology and risk factors, Clinical & Experimental Allergy, 20097. ,
DOI : 10.1111/j.1365-2222.2009.03323.x
Major carboxypeptidase N deficiency, Clinica Chimica Acta, vol.389, issue.1-2, pp.181-182, 2008. ,
DOI : 10.1016/j.cca.2007.11.008
Omapatrilat- the story of Overture and Octave, International Journal of Cardiology, vol.86, issue.1, pp.1-4, 2002. ,
DOI : 10.1016/S0167-5273(02)00389-3
Recent clinical trials with omapatrilat: New developments, Current Hypertension Reports, vol.12, issue.3, pp.346-352 ,
DOI : 10.1161/01.CIR.103.6.904
Losartan Increases Bradykinin Levels in Hypertensive Humans. Circulation, pp.315-320, 2005. ,
Pharmacokinetics of dipeptidylpeptidase-4 inhibitors. Diabetes, Obesity and Metabolism, pp.648-658, 2010. ,
Dipeptidyl Peptidase IV in Angiotensin-Converting Enzyme Inhibitor Associated Angioedema, Hypertension, vol.51, issue.1, pp.141-147, 2008. ,
DOI : 10.1161/HYPERTENSIONAHA.107.096552
Dipeptidyl Peptidase-IV Inhibitor Use Associated With Increased Risk of ACE Inhibitor-Associated Angioedema, Hypertension, vol.54, issue.3, pp.516-523, 2009. ,
DOI : 10.1161/HYPERTENSIONAHA.109.134197
Management and diagnostic guidelines for urticaria and angio-oedema, British Journal of Dermatology, vol.81, issue.4, pp.708-714, 2001. ,
DOI : 10.1046/j.1365-2133.1998.02175.x
Potential role of vasomotor effects of fibrinogen in bradykinin-induced angioedema, Journal of Allergy and Clinical Immunology, vol.121, issue.4, pp.969-975, 2008. ,
DOI : 10.1016/j.jaci.2008.01.071
Increased C-reactive protein in ACE-inhibitor-induced angioedema, British Journal of Clinical Pharmacology, vol.268, issue.2, pp.233-238, 2005. ,
DOI : 10.1016/S0024-3205(01)01129-8
Clinical characteristics of angiotensinconverting enzyme inhibitorinduced angioedema. Annals of Emergency Medicine, Mai, vol.20, issue.5, pp.555-558, 1991. ,
Episodic Macroglossia as the Sole Manifestation of Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema, Annals of Otology, Rhinology & Laryngology, vol.113, issue.3 ,
DOI : 10.1177/000348940311200714
Penile angioedema associated with the use of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers, American Journal of Health-System Pharmacy, vol.65, issue.5, pp.420-421, 2008. ,
DOI : 10.2146/ajhp070299
Isolated visceral angioedema: an underdiagnosed complication of ACE inhibitors? Mayo Clin Proc, pp.1201-1205, 2000. ,
Angiotensin-Converting Enzyme Inhibitor Angioedema of the Intestine: A Case Report and Review of the Literature, The American Journal of the Medical Sciences, vol.324, issue.2, pp.106-108, 2002. ,
DOI : 10.1097/00000441-200208000-00011
Fatal Angioedema Associated with Enalapril., Internal Medicine, vol.32, issue.4, pp.308-310, 1993. ,
DOI : 10.2169/internalmedicine.32.308
Revue sommaire sur les implications anesth??siques de l?????d??me de Quincke et des inhibiteurs de l???enzyme de conversion de l???ngiotensine, Canadian Journal of Anesthesia/Journal canadien d'anesth??sie, vol.25, issue.Suppl2, pp.994-1003, 2006. ,
DOI : 10.1177/000348940111000906
Angiotensin-Converting Enzyme Inhibitor-Induced Angioedema: A Multicenter Review and an Algorithm for Airway Management, Annals of Otology, Rhinology & Laryngology, vol.32, issue.9, pp.834-840, 2001. ,
DOI : 10.1016/S0091-6749(96)70151-3
Erythema Marginatum and Hereditary Angioedema, Southern Medical Journal, vol.97, issue.10, pp.948-50, 2004. ,
DOI : 10.1097/01.SMJ.0000140850.22535.FA
Treatment of angiotensin-converting enzyme inhibitor???related angioedema with the bradykinin B2 receptor antagonist icatibant, Journal of the American Academy of Dermatology, vol.63, issue.5, 2010. ,
DOI : 10.1016/j.jaad.2010.03.023
Therapeutic Efficacy of Icatibant in Angioedema Induced by Angiotensin-Converting Enzyme Inhibitors: A Case Series, Annals of Emergency Medicine, vol.56, issue.3, 2010. ,
DOI : 10.1016/j.annemergmed.2010.03.032
Angioedema from angiotensin-converting enzyme (ACE) inhibitor treated with complement 1 (C1) inhibitor concentrate, Acta Anaesthesiologica Scandinavica, vol.5, issue.Suppl. 1, pp.120-122, 20061. ,
DOI : 10.2165/00126839-200405060-00006
Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema*, Clinical Pharmacology & Therapeutics, vol.8, issue.1, 1996. ,
DOI : 10.1097/00004872-199112006-00164
Increased sensitivity to bradykinin among African Americans, Journal of Allergy and Clinical Immunology, vol.98, issue.2, pp.283-287, 1996. ,
DOI : 10.1016/S0091-6749(96)70151-3
Angiooedèmes et inhibiteurs de l'enzyme de conversion de l'angiotensine : à propos de 19 cas. La Revue de Médecine Interne, Juillet, vol.25, issue.7, pp.501-506, 2004. ,
Incidence and Characteristics of Angioedema Associated With Enalapril, Archives of Internal Medicine, vol.165, issue.14, pp.1637-1642, 2005. ,
DOI : 10.1001/archinte.165.14.1637
Potential genetic risk factors in angiotensin-converting enzyme-inhibitor-induced angio-oedema, British Journal of Clinical Pharmacology, vol.16, issue.2, pp.179-186, 2010. ,
DOI : 10.1161/01.CIR.97.14.1411
A Variant in XPNPEP2 Is Associated with Angioedema Induced by Angiotensin I???Converting Enzyme Inhibitors, The American Journal of Human Genetics, vol.77, issue.4, pp.617-626, 2005. ,
DOI : 10.1086/496899
Sex-dependent and race-dependent association of XPNPEP2 C-2399A polymorphism with angiotensin-converting enzyme inhibitor-associated angioedema, Pharmacogenetics and Genomics, vol.20, issue.9, pp.532-536, 2010. ,
DOI : 10.1097/FPC.0b013e32833d3acb
ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf, pp.171-88, 1998. ,
Les angioedèmes bradykiniques (AO) : définition clinique. Fiche de travail CHU Grenoble, 2001. ,
Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Use, Archives of Internal Medicine, vol.164, issue.8, pp.910-913, 2004. ,
DOI : 10.1001/archinte.164.8.910
Recurrent angiotensin-converting enzyme inhibitor-associated angioedema, JAMA. Juillet, vol.16278, issue.3, pp.232-235, 1997. ,
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol, The Lancet, vol.359, issue.9311, pp.995-1003, 2002. ,
DOI : 10.1016/S0140-6736(02)08089-3
Angioedema induced by angiotensin II blocker telmisartan, Allergy, vol.90, issue.5, pp.454-454, 2003. ,
DOI : 10.1056/NEJM199512073332316
Can angiotensin receptor antagonists be used safely in patients with previous ACE inhibitor-induced angioedema? Drug Saf, pp.73-79, 2002. ,
Angiotensin II Receptor Blocker???Associated Angioedema: On the Heels of ACE Inhibitor Angioedema, Pharmacotherapy, vol.90, issue.6, pp.1173-1178, 2002. ,
DOI : 10.1001/archderm.133.8.972
Clinical Profile of Angioedema Associated With Angiotensin Converting-Enzyme Inhibition, JAMA: The Journal of the American Medical Association, vol.260, issue.7, pp.967-70, 1988. ,
DOI : 10.1001/jama.1988.03410070095035
Effects of intradermal bradykinin after inhibition of angiotensin converting enzyme., BMJ, vol.294, issue.6580, pp.1119-1120, 1987. ,
DOI : 10.1136/bmj.294.6580.1119
Cough and Angioneurotic Edema Associated with Angiotensin-Converting Enzyme Inhibitor Therapy, Annals of Internal Medicine, vol.117, issue.3, pp.234-276, 1992. ,
DOI : 10.7326/0003-4819-117-3-234
Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitorassociated angioedema, Immunopharmacology, vol.43, pp.2-3293, 1999. ,
Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor???induced peritracheal edema, Journal of Allergy and Clinical Immunology, vol.120, issue.2, pp.403-408, 2007. ,
DOI : 10.1016/j.jaci.2007.04.012
kinin receptors, American Journal of Physiology-Heart and Circulatory Physiology, vol.286, issue.3, pp.926-932, 2004. ,
DOI : 10.1097/00004872-199816121-00026
Angio-??d??mes iatrog??nes: r??le des??inhibiteurs de??l'enzyme de??conversion et??des??antagonistes des??r??cepteurs ????l'angiotensine II (sartans), N??phrologie & Th??rapeutique, vol.3, issue.3, pp.89-95, 2007. ,
DOI : 10.1016/j.nephro.2007.03.003
Angiotensin-converting enzyme inhibitor???induced angioedema in a community hospital emergency department, Annals of Allergy, Asthma & Immunology, vol.103, issue.6, pp.502-509, 2009. ,
DOI : 10.1016/S1081-1206(10)60267-0
Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers, Annals of Allergy, Asthma & Immunology, vol.98, issue.1, pp.57-63, 2007. ,
DOI : 10.1016/S1081-1206(10)60860-5
Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events, New England Journal of Medicine, vol.3358, issue.15, pp.1547-1559, 2008. ,